Collection of Blood From Patients With Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational Cancer Institute (NCI)
About this trial
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment.
Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.
...
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Primary clinical; healthy volunteers may include NIH employees
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,750 Participants
are grouped into 2 trial groupsGroup A: Healthy Volunteers
Group B: Participants
Trial outcomes
Primary outcomes
1
Undertake genetic analysis of both prokaryotic and eukaryotic samples for advanced mutational analysis.
Undertake genetic analysis of both prokaryotic and eukaryotic samples for advanced mutational analysis.
Time frame
ongoing2
Correlate analysis results with clinical parameters such as demographics, toxicities, and treatment outcomes.
Correlate analysis results with clinical parameters such as demographics, toxicities, and treatment outcomes.
Time frame
ongoing3
Collection of tissue, urine, saliva, stool and blood components, which include serum, leukocytes, peripheral blood mononuclear cells (PBMC), and circulating tumor cells (cTC), of human subjects.
Analyze tissue, urine, saliva, stool and blood components, which include serum, leukocytes, peripheral blood mononuclear cells (PBMC), and circulating tumor cells (cTC), of human subjects.
Time frame
ongoingSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov